Biol Reprod Track the topics, authors and articles important to you
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van der Schoot, P.
Right arrow Articles by Uilenbroek, J. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van der Schoot, P.
Right arrow Articles by Uilenbroek, J. T.
Agricola
Right arrow Articles by van der Schoot, P.
Right arrow Articles by Uilenbroek, J. T.

Biology of Reproduction, Vol 27, 189-199, Copyright © 1982 by Society for the Study of Reproduction

ARTICLES

Atresia of preovulatory follicles in rats treated with sodium pentobarbital: effects of bromocriptine

P van der Schoot, D den Besten and JT Uilenbroek

Preovulatory rat follicles matured during normal cycles go gradually into atresia if ovulation is inhibited by injections of sodium pentobarbital from proestrus for 2 or more days. The gradual process of atresia is characterized by a rapid decrease of follicular estrogen secretion within 1 day after the start of pentobarbital injections. Furthermore, structural signs of atresia appear in predictable order during the ensuing 3 days. In the present study experiments are described demonstrating clear and reproducible effects of daily treatment with bromocriptine on the above processes. Bromocriptine delayed the decrease of follicular estrogen production by about 1 day and also delayed the occurrence of structural signs of atresia. Further study revealed that the effect on estrogen secretion was likely through the action of bromocriptine to suppress prolactin secretion. It thus seems that prolactin is involved in the mechanisms whereby preovulatory follicles lose their capacity to secrete estrogen. This effect of prolactin may occur at the ovarian level and, thus, be involved in reduced secretion of estrogen by the ovaries during physiological or pathological hyperprolactinemic states.




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1982 by the Society for the Study of Reproduction.